The Eye Institute of Utah | Salt Lake City, UT
Status
Conditions
Treatments
About
The purpose of this study is to evaluate the safety and effectiveness of Clareon™ PanOptix™ Pro Trifocal Intraocular Lens (IOL) compared to Clareon™ PanOptix™ Trifocal IOL.
Full description
Subjects will attend 9 scheduled study visits for a total individual duration of participation of approximately 7 months. The primary endpoint will be assessed at the Month 2 follow-up visit. Both eyes of a subject must qualify for enrollment into this study.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria:
Key Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
79 participants in 2 patient groups
Loading...
Central trial contact
Alcon Call Center
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal